Distinguished Professor Philippos Patsalis is a world-class geneticist, researcher and successful business entrepreneur, who has been leading public and private sector organizations since 1993. Prof. Patsalis held numerous executive positions and he served on several international scientific and business Boards, Committees and Councils during his 25-year distinguished career. Most notably, he held the presidential-appointed position of Minister of Health of the Republic of Cyprus. During his tenure as a Health Minister and under austere IMF, European Central Bank and European Commission economic measures, Prof. Patsalis implemented major reforms on the national healthcare sector. Among others, he restructured the operations of pharmaceuticals, he initiated the autonomization of public hospitals, and he introduced a new healthcare system.
He is currently the CEO and CMO of NIPD Genetics Public Company, a company he founded and has been successfully leading since its inception in 2010. NIPD Genetics is an international biotechnology company and a key-player within the competitive non-invasive genetic diagnostics field. Its focus is on developing and providing to the international market innovative technologies and products and it has demonstrated substantial growth.
Earlier in his career, Prof. Patsalis was for 10 year the founder and director of both The Department of Cytogenetics and Genomics and Translational Genetics and for 8 years the Chief Executive Director of The Cyprus Institute of Neurology and Genetics, the largest and most technologically advanced research institute of Cyprus. During his leadership the Institute achieved tremendous growth and international recognition as a center of excellence. Prof. Patsalis was also the founder of the Akeso Fertility Center Company and the founder of The Cyprus School of Molecular Medicine, an academic school for graduate education for which he served as its first Professor, Provost and Chief Executive Director.
Prof. Patsalis is an accomplished executive director, researcher and entrepreneur who has been bestowed with more than 30 national and international awards and distinctions for his contribution to science, innovation and business. Namely, the US-State Alumni Award of USA State Department, the National Award for Contribution to Scientific Research by the President of the Republic of Cyprus, and The Silver Medal of the Parliament – the highest honor of distinction by the Parliament of the Republic of Cyprus. He filed multiple patents, contributed to over 10 books, has published more than 130 peer-reviewed scientific papers in prestigious Journals, and has been invited to lecture in over 200 institutions, universities and conferences. He obtained more than 40 competitive research grants for tens of millions, including the very prestigious ERC Advance Grant and raised tens of millions of capital investments from individual and investments funds. He currently also holds the title of Professor of Human Genetics of the University of Nicosia Medical School.
Prof. Patsalis is actively involved with Institutions, Councils and company Boards that play a significant role in shaping and structuring policies in public and private organizations. He is the President of the National Board for Research and Innovation (CY), an elected member of the Board of the European Society of Human Genetics (EU) and a Board member of MANA Products Ltd (USA) among others. Prof. Patsalis is an ardent proponent of responsible scientific and business progress and champions the advancement of research, innovation and entrepreneurship.
Prof. Philippos Patsalis received his BSc degree from the Aristotelian University of Salonica, Greece and his MA, MPh and PhD degrees from the City University of New York. He underwent specialization and post-doctoral training at Cornel Medical Center, New York University, Memorial Sloan Kettering Cancer Center and Columbia University. He is a Certified and Accredited Laboratory Director in Cytogenetics and Molecular Genetics by the New York Department of Health and by the College of American Pathologists. In addition, he is a Certified High Complexity Laboratory Director by the American Board of Bioanalysis.